Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 5 de 5
Filter
Add more filters










Database
Language
Publication year range
1.
Noncoding RNA ; 10(1)2024 Jan 10.
Article in English | MEDLINE | ID: mdl-38250805

ABSTRACT

A characteristic of the cellular response to stress is the production of RNAs generated from a readthrough transcription of genes, called downstream-of-gene-(DoG)-containing transcripts. Additionally, transcription inhibitor drugs are candidates for fighting cancer. In this work, we report the results of a bioinformatic analysis showing that one of the responses to transcription inhibition is the generation of DoGs in cancer cells. Although some genes that form DoGs were shared between the two cancer lines, there did not appear to be a functional correlation between them. However, our findings show that DoGs are generated as part of the cellular response to transcription inhibition like other types of cellular stress, suggesting that they may be part of the defense against transcriptional stress.

2.
Nat Commun ; 14(1): 3435, 2023 06 10.
Article in English | MEDLINE | ID: mdl-37301863

ABSTRACT

Transcription and splicing are intrinsically coupled. Alternative splicing of internal exons can fine-tune gene expression through a recently described phenomenon called exon-mediated activation of transcription starts (EMATS). However, the association of this phenomenon with human diseases remains unknown. Here, we develop a strategy to activate gene expression through EMATS and demonstrate its potential for treatment of genetic diseases caused by loss of expression of essential genes. We first identified a catalog of human EMATS genes and provide a list of their pathological variants. To test if EMATS can be used to activate gene expression, we constructed stable cell lines expressing a splicing reporter based on the alternative splicing of motor neuron 2 (SMN2) gene. Using small molecules and antisense oligonucleotides (ASOs) currently used for treatment of spinal muscular atrophy, we demonstrated that increase of inclusion of alternative exons can trigger an activation of gene expression up to 45-fold by enhancing transcription in EMATS-like genes. We observed the strongest effects in genes under the regulation of weak human promoters located proximal to highly included skipped exons.


Subject(s)
Muscular Atrophy, Spinal , RNA Splicing , Humans , Alternative Splicing/genetics , Exons/genetics , Promoter Regions, Genetic/genetics , Cell Line , Muscular Atrophy, Spinal/metabolism , Survival of Motor Neuron 1 Protein/genetics
3.
IBRO Neurosci Rep ; 13: 543-551, 2022 Dec.
Article in English | MEDLINE | ID: mdl-36471713

ABSTRACT

SH-SY5Y is a cell line derived from human neuroblastoma. It is one of the most widely used in vitro models to study Parkinson's disease. Surprisingly, it has been found that it does not develop a dopaminergic phenotype after differentiation, questioning its usefulness as a Parkinson's model. There are other in vitro models with better dopaminergic characteristics. BE (2)-M17 is a human neuroblastoma cell line that differentiates when treated with retinoic acid. We compared the dopaminergic and serotonergic properties of both cell lines. BE (2)-M17 has higher basal levels of dopaminergic markers and acquires a serotonergic phenotype during differentiation while maintaining the dopaminergic phenotype. SH-SY5Y has higher basal levels of serotonergic markers but does not acquire a dopaminergic phenotype upon differentiation.

4.
Biochim Biophys Acta Rev Cancer ; 1876(2): 188620, 2021 12.
Article in English | MEDLINE | ID: mdl-34454982

ABSTRACT

Cancer cells require high levels of transcription to survive and maintain their cancerous phenotype. For several years, global transcription inhibitors have been used in the treatment of cancer. However, recent advances in understanding the functioning of the basal transcription machinery and the discovery of new drugs that affect the components of this machinery have generated a new boom in the use of this type of drugs to treat cancer. Inhibiting transcription at the global level in the cell generates a stress situation in which the cancer cell responds by overexpressing hundreds of genes in response to this transcriptional stress. Many of these over-transcribed genes encode factors that may be involved in the selection of cells resistant to the treatment and with a greater degree of malignancy. In this study, we reviewed various examples of substances that inhibit global transcription, as well as their targets, that have a high potential to be used against cancer. We also analysed what kinds of genes are overexpressed in the response to transcriptional stress by different substances and finally we discuss what types of studies are necessary to understand this type of stress response to have more tools to fight cancer.


Subject(s)
Neoplasms/genetics , Neoplasms/therapy , Stress, Physiological/genetics , Transcription Factors/genetics , Humans , Transcription, Genetic
5.
Open Biol ; 10(6): 200050, 2020 06.
Article in English | MEDLINE | ID: mdl-32543350

ABSTRACT

Disruption of the enzymatic activities of the transcription factor TFIIH by the small molecules Triptolide (TPL) or THZ1 could be used against cancer. Here, we used the MCF10A-ErSrc oncogenesis model to compare the effect of TFIIH inhibitors between transformed cells and their progenitors. We report that tumour cells exhibited highly increased sensitivity to TPL or THZ1 and that the combination of both had a synergic effect. TPL affects the interaction between XPB and p52, causing a reduction in the levels of XPB, p52 and p8, but not other TFIIH subunits. RNA-Seq and RNAPII-ChIP-Seq experiments showed that although the levels of many transcripts were reduced, the levels of a significant number were increased after TPL treatment, with maintained or increased RNAPII promoter occupancy. A significant number of these genes encode for factors that have been related to tumour growth and metastasis, suggesting that transformed cells might rapidly develop resistance to TPL/THZ inhibitors. Some of these genes were also overexpressed in response to THZ1, of which depletion enhances the toxicity of TPL, and are possible new targets against cancer.


Subject(s)
Breast Neoplasms/metabolism , Cell Transformation, Neoplastic/drug effects , Diterpenes/pharmacology , Phenanthrenes/pharmacology , Phenylenediamines/pharmacology , Pyrimidines/pharmacology , Transcription Factor TFIIH/antagonists & inhibitors , Breast Neoplasms/drug therapy , Cell Line, Tumor , Cell Transformation, Neoplastic/genetics , DNA Helicases/metabolism , DNA-Binding Proteins/metabolism , Epoxy Compounds/pharmacology , Female , Gene Expression Profiling , Gene Expression Regulation, Neoplastic/drug effects , Humans , MCF-7 Cells , Models, Biological , Molecular Dynamics Simulation , Sequence Analysis, RNA
SELECTION OF CITATIONS
SEARCH DETAIL
...